Loading company details...
Beta
Latest Form 4 (Oct 2, 2026): Hollings Renton (Director): Exercise/Conversion of 5,000 shares, $90.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 2, 2026 | Hollings Renton | Exercise/Conversion | 5,000 | $90.2K |
| Sep 17, 2026 | John A. Orwin | Exercise/Conversion | 1,300 | n/a |
| Aug 7, 2026 | Paul F. Lizzul, Chief Medical Officer | Grant/Award | 16,667 | n/a |
| Aug 7, 2026 | Daniel Faga, President, CEO | Grant/Award | 53,334 | n/a |
| Jun 17, 2026 | John P. Schmid | Exercise/Conversion | 6,030 | n/a |
| Jun 17, 2026 | Hollings Renton | Exercise/Conversion | 6,030 | n/a |
| Jun 17, 2026 | John A. Orwin | Exercise/Conversion | 6,030 | n/a |
| May 13, 2026 | Owen Hughes | Grant/Award | 11,250 | n/a |
| May 13, 2026 | Christopher M. Murphy, Chief Financial Officer | Grant/Award | 25,765 | n/a |
| Apr 29, 2026 | Susannah Gray | Grant/Award | 11,250 | n/a |